There is a strong need for medication that treats age-related degenerative muscle and tendon diseases. A critical bottleneck in the discovery and development of novel drugs for skeletal muscle is the lack of efficient and robust functional in vitro assays for compound screening. In a SLAS Technology original research article, researchers in Switzerland describe the development of a screening platform with automated production of 3D muscle- a...